An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer-Reference-Cited by-同舟云学术

An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancer

Published:2020-04 Issue: Volume:145 Page:209-214
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Nantavithya Chonnipa,Gomez Daniel R.,Chang Joe Y.^ORCID,Mohamed Abdallah S.R.,Fuller C. David,Li Heng,Brooks Eric D.,Gandhi Saumil J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference38 articles.

1. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study;Fakiris;Int J Radiat Oncol Biol Phys,2009

2. Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy;Haasbeek;Cancer,2010

3. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study;McGarry;Int J Radiat Oncol Biol Phys,2005

4. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2005

5. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study;Onishi;Cancer,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical association between plan complexity and the local-recurrence-free-survival of non-small-cell lung cancer patients receiving stereotactic body radiation therapy;Physica Medica;2024-06

2. Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status;Cancer Medicine;2022-12-16

3. Is it necessary to prescribe the same dose to subclinical lesions as gross tumor volume in non-small-cell lung cancer? —a failure pattern analysis;2022-10-13

4. Flattening filter free stereotactic body radiation therapy for lung tumors: outcomes and predictive factors;Translational Cancer Research;2021-02